Eric Jonasch
0000-0003-0943-2806
7 papers found
Refreshing results…
Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study
Systemic Therapy Development in Von Hippel–Lindau Disease: An Outsized Contribution from an Orphan Disease
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers
Summary from the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research
Missing publications? Search for publications with a matching author name.